Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYTO-PV hematocrit target trial in polycythemia vera
2007-006694-91Phase 3Terminated
- Sponsor
- GIMEMA
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hydroxyurea in polycythemia vera (PV) (2 arms), sponsored by GIMEMA. Started Jun 2008; status: terminated.
02
Drugs
hydroxyurea
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on 2007-006694-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006694-91.